Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul de Lay

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
New Directions for Evaluation|April 22, 2020
Politics of monitoring and evaluation: Lessons from the AIDS epidemicPaul De Lay, Valerie Manda
BMC Public Health|July 23, 2013
Determinants of government HIV/AIDS financing: a 10-year trend analysis from 125 low- and middle-income countriesCarlos Ávila, Dejan Loncar, Peter Amico, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 11, 2009
Are we on course for reporting on the Millennium Development Goals in 2015?Deborah Rugg, Hein Marais, Michel Carael, et al.
BMC Public Health|March 23, 2012
Pattern and levels of spending allocated to HIV prevention programs in low- and middle-income countriesPeter Amico, Benjamin Gobet, Carlos Avila-Figueroa, et al.
Pharmacoeconomics|July 27, 2012
Counting the cost of not costing HIV health facilities accurately: pay now, or pay more laterEduard J Beck, Carlos Avila, Sofia Gerbase, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 15, 2013
Costs and cost-effectiveness of HIV community services: quantity and quality of studies published 1986-2011Eduard J Beck, Olufunke Fasawe, Patricia Ongpin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 11, 2009
Financing the response to HIV in low-income and middle-income countriesJosé Antonio Izazola-Licea, Jan Wiegelmann, Christian Arán, et al.
Antiviral Therapy|October 14, 2014
Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for healthEduard J Beck, Carlos Passarelli, Iris Lui, et al.
Plos One|April 5, 2013
Cost-effectiveness analysis of Option B+ for HIV prevention and treatment of mothers and children in MalawiOlufunke Fasawe, Carlos Avila, Nathan Shaffer, et al.
Science (New York, N.Y.)|February 4, 2006
The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countriesJohn Stover, Stefano Bertozzi, Juan-Pablo Gutierrez, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
New Directions for Evaluation|April 22, 2020
Politics of monitoring and evaluation: Lessons from the AIDS epidemicPaul De Lay, Valerie Manda
BMC Public Health|July 23, 2013
Determinants of government HIV/AIDS financing: a 10-year trend analysis from 125 low- and middle-income countriesCarlos Ávila, Dejan Loncar, Peter Amico, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 11, 2009
Are we on course for reporting on the Millennium Development Goals in 2015?Deborah Rugg, Hein Marais, Michel Carael, et al.
BMC Public Health|March 23, 2012
Pattern and levels of spending allocated to HIV prevention programs in low- and middle-income countriesPeter Amico, Benjamin Gobet, Carlos Avila-Figueroa, et al.
Pharmacoeconomics|July 27, 2012
Counting the cost of not costing HIV health facilities accurately: pay now, or pay more laterEduard J Beck, Carlos Avila, Sofia Gerbase, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 15, 2013
Costs and cost-effectiveness of HIV community services: quantity and quality of studies published 1986-2011Eduard J Beck, Olufunke Fasawe, Patricia Ongpin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 11, 2009
Financing the response to HIV in low-income and middle-income countriesJosé Antonio Izazola-Licea, Jan Wiegelmann, Christian Arán, et al.
Antiviral Therapy|October 14, 2014
Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for healthEduard J Beck, Carlos Passarelli, Iris Lui, et al.
Plos One|April 5, 2013
Cost-effectiveness analysis of Option B+ for HIV prevention and treatment of mothers and children in MalawiOlufunke Fasawe, Carlos Avila, Nathan Shaffer, et al.
Science (New York, N.Y.)|February 4, 2006
The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countriesJohn Stover, Stefano Bertozzi, Juan-Pablo Gutierrez, et al.
Pageof 1